Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
| Author: Oliver Gassmann, Alexander Schuhmacher, Max Von Zedtwitz, Gerrit Reepmeyer
| Publisher: Springer
| Publication Date: Jan 12, 2019
| Number of Pages: 194 pages
| Language: English
| Binding: Paperback
| ISBN-10: 303009782X
| ISBN-13: 9783030097820
Additional Information
Author:
Oliver Gassmann, Alexander Schuhmacher, Max Von Zedtwitz, Gerrit Reepmeyer